BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2021
View Archived Issues
FDA clears IND application for phase II study of LPCN-1154 in postpartum depression
Read More
LEO Pharma initiates phase IIa study of LEO-152020 in cholinergic urticaria
Read More
LLT1 is a poor prognostic factor in HPV-negative oropharyngeal SCC
Read More
Veraxa partners with Quadira on ADCs for oncology indications
Read More
Avidea advances lead SNAPvax TV candidate for MS toward clinic
Read More
CAMP4 raises funds to expand its platform and advance multiple RNA therapies
Read More
Otonomy announces phase I/II study expansion for OTO-413 in speech-in-noise hearing difficulty
Read More
Chinese researchers patent NMDA receptor antagonists
Read More
Medshine Discovery discloses ROS1 inhibitors
Read More
Shenzhen Salubris Pharmaceuticals synthesizes FXIa inhibitors
Read More
FDA authorizes phase Ib/II study of Anktiva plus chemoimmunotherapy in TNBC
Read More
Nankai University identifies new compounds for skin injury
Read More
CRISPR and Capsida enter strategic collaboration to develop gene-edited therapies
Read More
Lentigen Technology presents new CAR cells for cancer immunotherapy
Read More
Investigator-initiated study of Salarius' seclidemstat in hematologic cancers begins
Read More
Differences in tumor uptake between [18F]FP-R01-MG-F2 and FDG in pancreatic cancer
Read More
Tylenol could find role in gene therapy
Read More
Positive safety data reported from cohort 1 of OASIS study evaluating CLS-AX in wet AMD
Read More
FDA clears IND application for anti-CCR8 antibody JTX-1811
Read More
FDA approves IND for phase IIb PORTICO study of vafidemstat in borderline personality disorder
Read More
Linnaeus and Merck & Co. expand collaborative evaluation of LNS-8801 with Keytruda
Read More
First-in-human data for FLT3 inhibitor FF-10101
Read More
ORIN-1001 shows promising preliminary antitumor activity in heavily pretreated solid tumors
Read More
Ashvattha reports phase II interim data on OP-101 to treat hyperinflammation in severe COVID-19
Read More
Harbour BioMed and Dana-Farber Cancer Institute to codevelop novel biotherapies for cancer
Read More
Servier and Oncodesign's collaboration in Parkinson's selects preclinical candidate
Read More
Spero initiates new phase I trials of SPR-206 for MDR Gram-negative infections
Read More
Mnemo Therapeutics to accelerate development of EnfiniT platform
Read More
SOX2 predicts laryngeal cancer risk in patients with premalignant lesions
Read More
Daiichi Sankyo discontinues development of nafamostat inhalation formulation for COVID-19 in Japan
Read More